These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26918001)

  • 1. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids.
    Brölmann H; Bongers M; Garza-Leal JG; Gupta J; Veersema S; Quartero R; Toub D
    Gynecol Surg; 2016; 13():27-35. PubMed ID: 26918001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study.
    Bongers M; Brölmann H; Gupta J; Garza-Leal JG; Toub D
    Gynecol Surg; 2015; 12(1):61-70. PubMed ID: 25774122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Clinical Outcomes of Transcervical Radiofrequency Ablation of Uterine Fibroids: The VITALITY Study.
    Garza-Leal JG
    J Gynecol Surg; 2019 Feb; 35(1):19-23. PubMed ID: 30713407
    [No Abstract]   [Full Text] [Related]  

  • 4. Transcervical fibroid ablation with the Sonata™ system for treatment of submucous and large uterine fibroids.
    Shifrin G; Engelhardt M; Gee P; Pschadka G
    Int J Gynaecol Obstet; 2021 Oct; 155(1):79-85. PubMed ID: 33544889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results.
    Christoffel L; Römer T; Schiermeier S
    Med Devices (Auckl); 2021; 14():77-84. PubMed ID: 33688276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata.
    Lukes A; Green MA
    J Gynecol Surg; 2020 Oct; 36(5):228-233. PubMed ID: 33061253
    [No Abstract]   [Full Text] [Related]  

  • 7. The INTEGRITY Trial: Preservation of Uterine-Wall Integrity 12 Months After Transcervical Fibroid Ablation with the Sonata System.
    Bongers M; Gupta J; Garza-Leal JG; Brown M; Felberbaum R
    J Gynecol Surg; 2019 Oct; 35(5):299-303. PubMed ID: 31602171
    [No Abstract]   [Full Text] [Related]  

  • 8. A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata System.
    Toub DB
    Curr Obstet Gynecol Rep; 2017; 6(1):67-73. PubMed ID: 28357157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What predicts durable symptom relief of uterine fibroids treated with MRI-guided focused ultrasound? A multicenter trial in 8 academic centers.
    Bitton RR; Fast A; Vu KN; Lum DA; Chen B; Hesley GK; Raman SS; Matsumoto AH; Price TM; Tempany C; Dhawan N; Dolen E; Kohi M; Fennessey FM; Ghanouni P
    Eur Radiol; 2023 Nov; 33(11):7360-7370. PubMed ID: 37553488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcervical Radiofrequency Ablation of Symptomatic Uterine Fibroids: 2-Year Results of the SONATA Pivotal Trial.
    Miller CE; Osman KM
    J Gynecol Surg; 2019 Dec; 35(6):345-349. PubMed ID: 32226268
    [No Abstract]   [Full Text] [Related]  

  • 11. 12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids.
    Hudgens J; Johns DA; Lukes AS; Forstein DA; Delvadia D
    Int J Womens Health; 2019; 11():387-394. PubMed ID: 31308763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the Sonata System: a retrospective follow-up study.
    van der Meulen JF; Cooijmans TH; van Zutven VJ; Leemans JC; Verhoeven CJ; Bongers MY
    AJOG Glob Rep; 2022 Nov; 2(4):100087. PubMed ID: 36536842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Intervention Trial on Tailored Radiofrequency Ablation of Uterine Myomas.
    Fasciani A; Turtulici G; Siri G; Ferrero S; Sirito R
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32178351
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrasound guided percutaneous radiofrequency thermal ablation of symptomatic uterine fibroids - results from a single center and 52 weeks of follow up.
    Yüce G; Tayarer A; Keskin HL; Genc B; Canyigit M
    Ginekol Pol; 2020; 91(8):447-452. PubMed ID: 32902841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
    Al-Hendy A; Bradley L; Owens CD; Wang H; Barnhart KT; Feinberg E; Schlaff WD; Puscheck EE; Wang A; Gillispie V; Hurtado S; Muneyyirci-Delale O; Archer DF; Carr BR; Simon JA; Stewart EA
    Am J Obstet Gynecol; 2021 Jan; 224(1):72.e1-72.e50. PubMed ID: 32702363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency Ablation for the Treatment of Uterine Fibroids: A Systematic Review and Meta-Analysis by the AAGL Practice Committee.
    Chen I; Berman JM; Balk EM; Saldanha IJ; Kowalczewski E; Yi J; Zanotti S; Al Hilli M; Kho KA
    J Minim Invasive Gynecol; 2024 Sep; ():. PubMed ID: 39277104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies.
    Bradley LD; Pasic RP; Miller LE
    J Laparoendosc Adv Surg Tech A; 2019 Dec; 29(12):1507-1517. PubMed ID: 31702440
    [No Abstract]   [Full Text] [Related]  

  • 18. Uterine Myoma Position-based Radiofrequency Ablation (UMP-b RFA): 36 months follow-up clinical outcomes.
    Fasciani A; Turtulici G; Pedullà A; Sirito R
    Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():23-28. PubMed ID: 36527825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of transcervical resection of submucous fibroids on menstrual blood loss: A prospective cohort study.
    Keizer AL; Jacobs BL; Thurkow AL; de Lange ME; Radder CM; van Kesteren PJM; Hanstede MMF; Huirne JAF; Hehenkamp WJK
    Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():128-135. PubMed ID: 35640441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
    Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
    Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.